Dr Reddy’s rallies 5% on smart Q2 numbers

INSUBCONTINENT EXCLUSIVE:
quarter grew 77 per cent. Net profit rose to Rs 504 crore in July-September against Rs 387.6 crore in the same quarter of FY18. Revenue
increased to Rs 3,797.80 crore in Q2 FY19 over Rs 3,720.70 crore a year ago. The scrip was 5.64 per cent up at Rs 2,539.50 at around 10.35
operational efficiency and cost optimisation are showing results
Looking ahead, our priority will be to resolve pending regulatory issues, and continue to work on execution and cost structures that will
generics pipeline, strong earnings revival and compelling valuations at 14.6x FY20E EPS render it a prime re-rating candidate